Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.41 |
| ▸ | HTR1A | P08908 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | HTR1D | P28221 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11769547 | 0.81 | CYP2C19 (0.43) | CYP2C19LMNACYP3A4CYP1A2CYP2D6 | |
| SCHEMBL9242528 | 0.80 | GAA (0.40) | LMNACYP3A4CYP1A2CYP2D6MEN1 | |
| SCHEMBL11099354 | 0.80 | CYP2C19 (0.42) | CYP2C19LMNACYP3A4CYP1A2CYP2D6 | |
| SCHEMBL11232750 | 0.80 | GAA (0.47) | CYP2C19LMNACYP3A4CYP1A2CYP2D6 | |
| SCHEMBL11583200 | 0.80 | HSPA5 (0.54) | CYP2C19LMNACYP3A4CYP1A2CYP2D6 | |
| SCHEMBL10873904 | 0.80 | TDP1 (0.47) | CYP2C19LMNACYP3A4CYP1A2CYP2D6 | |
| SCHEMBL11772892 | 0.80 | CYP2C19 (0.42) | CYP2C19LMNACYP3A4CYP1A2CYP2D6 | |
| SCHEMBL9721288 | 0.79 | HSPA5 (0.57) | CYP2C19CYP3A4CYP1A2CYP2D6MEN1 | |
| SCHEMBL31122152 | 0.79 | HSPA5 (0.57) | CYP2C19CYP3A4CYP1A2CYP2D6MEN1 | |
| SCHEMBL2265057 | 0.79 | GAA (0.55) | CYP2C19LMNACYP3A4CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | CYTEC TECHNOLOGY CORP. | 2009-08-13 | — | — | US | disclosed |
| WO-2007120749-A1 | STABILIZED SPANDEX COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | SMCHD1, SMC1A, SI | CYP2C19 561/4885LMNA 348/4885CYP3A4 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.